Chickadee Biomedicines, Inc.

Biotechnology company · Boston, Massachusetts, United States

Chickadee Biomedicines, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2025. It has reported private securities offerings to the US SEC, most recently $150,000 sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Chickadee Biomedicines at a glance

Typebiotechnology company

HeadquartersBoston, Massachusetts, United States

Earliest incorporation on record2025

SEC CIK2138882

What does Chickadee Biomedicines do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $150,000 sold (2026).

Frequently asked questions about Chickadee Biomedicines

Where is Chickadee Biomedicines headquartered?

Chickadee Biomedicines, Inc. is headquartered in Boston, Massachusetts, United States.

What does Chickadee Biomedicines do?

Chickadee Biomedicines, Inc. is a biotechnology company.

When was Chickadee Biomedicines founded?

The earliest incorporation on record for Chickadee Biomedicines, Inc. is in 2025, according to public company registers.

Similar companies

Syntis Bio, Inc.Boston, Massachusetts, United States
Strand Therapeutics Inc.Boston, Massachusetts, United States
Pear Therapeutics, Inc.Boston, Massachusetts, United States
Aura Biosciences, Inc.Boston, Massachusetts, United States
Holobiome, Inc.Boston, Massachusetts, United States
Leuko Labs, Inc.Boston, Massachusetts, United States
Compass Therapeutics, Inc.Boston, Massachusetts, United States
Odyssey Therapeutics, Inc.Boston, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences